An Observational Study Characterizing the Pain Response, Safety and Tolerability of CCTA320 (CANNABIS) in Patients with Chronic Pain


Overview

IRB Number: HS# 2021_6531

Condition/Disease:
Chronic pain

Lead Researcher:
Marcela Dominguez, MD

Location:
UCI Health – 2161 San Joaquin Hills Road, Newport Beach, CA 92660

Phone:
949-386-5700

Purpose:
This research study is a pilot study to assess the safety and efficacy of cannabis in chronic pain.

Findings

This study is meant to evaluate the safety and tolerability of cannabis (CCTA320) in subjects with chronic pain.

Participate

Eligibility:

  • Be 21 or older
  • Have failed to respond to 2 different types of medications.
  • Have purchased CANNACEUTICA at Kannabis Works (2106 S Susan St. Santa Ana, CA 92704)

Time Commitment:
This is a short-term study and will last about 14-16 weeks. Participants will receive study-related exams. The study will be conducted in South Orange County.

Benefits:
You may receive no direct benefit from being in this study. This study is meant to evaluate the safety and tolerability of cannabis (CCTA320) in subjects with chronic pain. This is an observational study.

Compensation:
Compensation is not available.

Treatment:
Cannabis – CCTA320 treatment

SEE IF YOU QUALIFY by filling out the questionnaire at:
https://www.niamedic-usa.com/ccta-pain-study

Contact:
Marcela Dominguez, MD  |  949-386-5700
Kelly Brink, RN  |  brinkK@hs.uci.edu